Tag: Personalized Immunotherapy for NHL

Home / Personalized Immunotherapy for NHL

Categories

A study of chimeric antigen receptor T lymphocytes (CAR-T) in the treatment of relapsed and refractory non-Hodgkin lymphoma

Detailed Description: This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis for collect...
personalized-immunotherapy-for-nhl

Scan the code